Search Results

There are 11533 results for: content related to: Eye complications of cetuximab therapy

  1. Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 128–155, Dr Benoit You and Dr Eric X. Chen

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010395940

  2. You have free access to this content
    Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: Results from a randomized trial of the GERMAN AIO CRC Study Group

    International Journal of Cancer

    Volume 132, Issue 1, 1 January 2013, Pages: 236–245, Sebastian Stintzing, Christine Kapaun, Rüdiger Paul Laubender, Andreas Jung, Jens Neumann, Dominik Paul Modest, Clemens Giessen, Nicolas Moosmann, Andreas Wollenberg, Thomas Kirchner and Volker Heinemann

    Version of Record online : 26 JUN 2012, DOI: 10.1002/ijc.27654

  3. Cetuximab-based therapy vs noncetuximab therapy in advanced or metastatic colorectal cancer: a meta-analysis of seven randomized controlled trials

    Colorectal Disease

    Volume 12, Issue 5, May 2010, Pages: 399–406, L. Liu, Y. Cao, A. Tan, C. Liao, Z. Mo and F. Gao

    Version of Record online : 15 APR 2009, DOI: 10.1111/j.1463-1318.2009.01916.x

  4. Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients

    Asia-Pacific Journal of Clinical Oncology

    Tetsuji Terazawa, Hitoshi Nishitani, Ken Kato, Hironobu Hashimoto, Kohei Akiyoshi, Yuriko Ito, Akihiro Nakamoto, Satoru Iwasa, Takako Eguchi Nakajima, Tetsuya Hamaguchi, Yasuhide Yamada and Yasuhiro Shimada

    Version of Record online : 6 AUG 2015, DOI: 10.1111/ajco.12405

  5. You have full text access to this Open Access content
    Safety and efficacy of cetuximab combined with chemotherapy in Chinese patients with advanced non-small cell lung cancer

    Thoracic Cancer

    Volume 3, Issue 2, May 2012, Pages: 188–193, Xiaoyan Si and Li Zhang

    Version of Record online : 3 MAY 2012, DOI: 10.1111/j.1759-7714.2011.00096.x

  6. You have free access to this content
    Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer

    Intervention Review

    The Cochrane Library

    Zu-Yao Yang, Li Liu, Chen Mao, Xin-Yin Wu, Ya-Fang Huang, Xue-Feng Hu and Jin-Ling Tang

    Published Online : 17 NOV 2014, DOI: 10.1002/14651858.CD009948.pub2

  7. You have full text access to this OnlineOpen article
    Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit

    Cancer Medicine

    Volume 4, Issue 1, January 2015, Pages: 65–74, Uma Raju, David P. Molkentine, David R. Valdecanas, Amit Deorukhkar, Kathryn A. Mason, Thomas A. Buchholz, Raymond E. Meyn, Kie-Kian Ang and Heath Skinner

    Version of Record online : 29 OCT 2014, DOI: 10.1002/cam4.345

  8. You have full text access to this Open Access content
    Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III

    Cancer Science

    Volume 99, Issue 10, October 2008, Pages: 2062–2069, Junya Fukai, Kazuto Nishio, Toru Itakura and Fumiaki Koizumi

    Version of Record online : 3 OCT 2008, DOI: 10.1111/j.1349-7006.2008.00945.x

  9. The role of cetuximab as first-line treatment of colorectal liver metastases


    Volume 15, Issue 1, January 2013, Pages: 11–17, Claire Jones, Mark A. Taylor and Billy McWilliams

    Version of Record online : 17 OCT 2012, DOI: 10.1111/j.1477-2574.2012.00591.x

  10. You have free access to this content
    Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody–drug conjugates by cholesterol sequestration

    International Journal of Cancer

    Volume 136, Issue 1, 1 January 2015, Pages: 182–194, Yang Chen, Guanghua Liu, Lifang Guo, Hui Wang, Yan Fu and Yongzhang Luo

    Version of Record online : 14 MAY 2014, DOI: 10.1002/ijc.28950

  11. Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck

    Head & Neck

    Volume 35, Issue 3, March 2013, Pages: 443–453, Dong M. Shin and Fadlo R. Khuri

    Version of Record online : 2 NOV 2011, DOI: 10.1002/hed.21910

  12. Antibody Conjugated PLGA Nanoparticles for Targeted Delivery of Paclitaxel Palmitate: Efficacy and Biofate in a Lung Cancer Mouse Model


    Volume 9, Issue 24, December 20, 2013, Pages: 4221–4236, Nour Karra, Taher Nassar, Alina Nemirovski Ripin, Ouri Schwob, Jürgen Borlak and Simon Benita

    Version of Record online : 21 JUL 2013, DOI: 10.1002/smll.201301417

  13. You have full text access to this OnlineOpen article
    A novel approach to predict cetuximab-induced hypersensitivity reaction: detection of drug-specific IgE on basophils

    Cancer Medicine

    Takuya Iwamoto, Akiharu Okamoto, Hajime Ishinaga, Kasumi Shimizu, Alberto A. Gayle, Naoya Arai, Kazuhiko Takeuchi and Masahiro Okuda

    Version of Record online : 16 FEB 2016, DOI: 10.1002/cam4.658

  14. Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy

    Intervention Review

    The Cochrane Library

    Kelvin KW Chan, Anne-Marie Glenny, Jo C Weldon, Susan Furness, Helen V Worthington and Helen Wakeford

    Published Online : 1 DEC 2015, DOI: 10.1002/14651858.CD010341.pub2

  15. You have free access to this content
    Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer


    Volume 119, Issue 11, 1 June 2013, Pages: 1941–1950, Janghee Woo, Neil Palmisiano, William Tester and John C. Leighton Jr.

    Version of Record online : 15 MAR 2013, DOI: 10.1002/cncr.27994

  16. You have free access to this content
    KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer


    Volume 119, Issue 4, 15 February 2013, Pages: 714–721, Chen Mao, Ya-Fang Huang, Zu-Yao Yang, Da-Yong Zheng, Jin-Zhang Chen and Jin-Ling Tang

    Version of Record online : 12 SEP 2012, DOI: 10.1002/cncr.27804

  17. You have free access to this content
    Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab–irinotecan

    British Journal of Clinical Pharmacology

    Volume 73, Issue 5, May 2012, Pages: 776–785, Marie-Christine Etienne-Grimaldi, Jaafar Bennouna, Jean-Louis Formento, Jean-Yves Douillard, Mireille Francoual, Isabelle Hennebelle, Etienne Chatelut, Eric Francois, Roger Faroux, Chaza El Hannani, Jacques-Henri Jacob and Gérard Milano

    Version of Record online : 5 APR 2012, DOI: 10.1111/j.1365-2125.2011.04141.x

  18. You have free access to this content
    A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment

    International Journal of Cancer

    Volume 131, Issue 4, 15 August 2012, Pages: 956–969, Hongzheng Zhang, Sujin Yun, Thil D. Batuwangala, Michael Steward, Steve D. Holmes, Lin Pan, Mourad Tighiouart, Hyung Ju C. Shin, Lydia Koenig, Wungki Park, Daniel Rycroft, Sreenivas Nannapaneni, Yuxiang Wang, Zhuo (Georgia) Chen and Dong M. Shin

    Version of Record online : 19 NOV 2011, DOI: 10.1002/ijc.26427

  19. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer

    Journal of the European Academy of Dermatology and Venereology

    Volume 24, Issue 4, April 2010, Pages: 453–459, J Ocvirk and S Cencelj

    Version of Record online : 27 SEP 2009, DOI: 10.1111/j.1468-3083.2009.03446.x

  20. You have full text access to this OnlineOpen article
    A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck

    Cancer Medicine

    Volume 3, Issue 6, December 2014, Pages: 1493–1501, Douglas Adkins, Jessica Ley, Farrokh Dehdashti, Marilyn J. Siegel, Tanya M. Wildes, Loren Michel, Kathryn Trinkaus and Barry A. Siegel

    Version of Record online : 1 AUG 2014, DOI: 10.1002/cam4.294